Create your own personalized MyJanssenCarePath account to:
- Learn about specific insurance coverage options
- Identify cost support options
- Sign up for personal treatment reminders
Patient Authorization Form — Allows you to authorize the use of your personal information for Janssen CarePath support programs.
Medicare Resource Guide — Provides information on sources for cost support that may be available to patients enrolled in Medicare.
Janssen CarePath Medicare Part D and Donut Hole Guide — Helps you understand the four phases of coverage (Deductible, Initial Coverage, Coverage Gap [Donut Hole], and Catastrophic Coverage [Safety Net]), and when you will enter a Donut Hole in 2019.
Medicare Low-Income Subsidy (LIS) Brochure — Offers information about extra help with prescription drug costs that is available to low-income residents of the United States enrolled in Medicare Prescription Drug Plans.
Advocacy Connector — A Janssen-sponsored resource that connects patients and caregivers to national and state-specific advocacy groups that offer resources that may be relevant to your needs.
Johnson & Johnson Patient Assistance Foundation (JJPAF) — An independent, nonprofit organization committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies.
WHAT IS PROCRIT®?
PROCRIT® (epoetin alfa) is used to treat a lower than normal number of red blood cells (anemia) caused by:
PROCRIT® may also be used to reduce the chance you will need red blood cell transfusions if you are scheduled for certain surgeries where a lot of blood loss is expected.
If your hemoglobin level stays too high or if your hemoglobin goes up too quickly, this may lead to serious health problems which may result in death. These serious health problems may happen if you take PROCRIT®, even if you do not have an increase in your hemoglobin level.
PROCRIT® has not been proven to improve quality of life, fatigue, or well-being.
PROCRIT® should not be used for treatment of anemia:
PROCRIT® should not be used to reduce the chance of red blood cell transfusions if:
It is not known if PROCRIT® is safe and effective in treating anemia in children less than 1 month old who have chronic kidney disease and in children less than 5 years old who have anemia caused by chemotherapy.
What is the most important information I should know about PROCRIT® (epoetin alfa)?
PROCRIT® may cause serious side effects that can lead to death, including:
For people with cancer:
Your tumor may grow faster and you may die sooner if you choose to take PROCRIT®. Your healthcare provider will talk with you about these risks.
For all people who take PROCRIT®, including patients with cancer or chronic kidney disease:
If you decide to take PROCRIT®, your healthcare provider should prescribe the smallest dose of PROCRIT® that is necessary to reduce your chance of needing red blood cell transfusions.
Who should not take PROCRIT®?
Do not take PROCRIT® if you:
Do not give PROCRIT® from multiple-dose vials to:
What should I tell my healthcare provider before taking PROCRIT®?
PROCRIT® may not be right for you. Tell your healthcare provider about all your health conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements.
What are the possible side effects of PROCRIT®?
PROCRIT® may cause serious side effects.
Common side effects of PROCRIT® include:
These are not all of the possible side effects of PROCRIT®. Your healthcare provider can give you a more complete list. Tell your healthcare provider about any side effects that bother you or that do not go away.
Please read the Medication Guide for PROCRIT® (epoetin alfa) and discuss it with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
080072 - 170908